Skip to main content

LIVE

DRIO

DarioHealth Corp.

DRIO

NASDAQ·Healthcare·Medical - Specialties·Mkt cap $52.9M

$7.24

+3.72%

P/E

2.19

Mkt Cap

$52.9M

52-Wk Range

$5.85–$17.74

52-Week Range

$5.85 - $17.74

P/E

2.19

Fwd P/E

-1.82

Beta

1.12

Div Yield

0.00%

Avg Vol

17.7K

Shares Out

7.3M

Mkt Cap

$52.9M

Price action

Price chart

Down 21.3% over the trailing year

Total returns

Price performance

Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.

Why we rate it this way

The thesis at a glance

Bull and bear case · plain-English context across the five lenses we evaluate.

Bull Case

4 reasons

  • Proprietary DarioEngage care management platform with integrated clinical workflows
  • FDA-cleared smart connected devices with Bluetooth-enabled ecosystem
  • Multi-therapeutic area approach addressing multiple chronic conditions
  • Direct-to-consumer and B2B2C distribution channels with payer relationships

Bear Case

1 risk

  • Average volatility.

Growth

Profitability at risk

Expansion of digital therapeutics adoption post-pandemic

Value

Deep value opportunity - significant discount to Life Sciences Tools peers

Momentum

Stable

-3.7% over 3m

Quality

Strong

Strong fundamentals

Dividend

None

No dividend

Earnings track record

Recent earnings results

AI-summarized recap of last quarter, plus the surprise on every print.

Next: Nov 12, 2026

Q3 26 RECAP

AUG 11, 2026

Reported EPS of -$0.85 vs -$1.22 consensus (+30.3% surprise). Revenue of $5.2M vs $5.9M expected (-12.6%).

EPS beat +30.3%
Revenue miss

EPS surprise · last 4Q

1 of 1 beats

Estimate

Actual

Q3 26

+30.3%

Revenue trend · last 8Q

+17%

-14%

-33%

-31%

-17%

-4%

Q3 24

Q4 24

Q1 25

Q2 25

Q3 25

Q4 25

Q1 26

Q2 26

$7.4M

$7.6M

$6.8M

$5.4M

$5.0M

$5.2M

$5.6M

$5.2M

Margins · last 8Q

Gross

61.7%

Operating

-125.2%

Profit

153.1%

Wall Street consensus

2 analysts · 50% Buy

Live ratings and price targets aggregated across covering analysts.

Buy

1

50%

Hold

1

50%

Sell

0%

Median Price Target

Latest: Stifel · May 14, 2026

vs Industry

How DRIO stacks vs Medical - Specialties

Stock metrics vs industry averages. Green = better than industry.

Industry comparison data unavailable for this stock.